Company intelligence / Profile preview

Narikka

Bedford, Massachusetts, United Stateswebtv.un.org ↗

Ownership: Private
Development stage: Other

Overview

Anika is a global leader in early intervention orthopedic care with a focus on joint preservation. Its portfolio includes commercialized viscosupplement injections for osteoarthritis pain management and regenerative products such as the Integrity Implant System for rotator cuff repairs. The company has recently divested non-core businesses to focus on its profitable hyaluronic acid-driven OA pain management and high-growth regenerative solutions portfolio.

Therapeutic areas: Rheumatology
Modalities: BiologicDeviceInjectable bone substitute
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Narikka.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Narikka.

Explore the full profile